• Go to navigation
  • Go to content
Welcome to Zomig.info!

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca
  • Zomig
  • Zomig Rapimelt
  • Zomig Nasal Spray

Main navigation

  • Home
  • Is it Migraine?
  • Learn About Migraine
  • Treating Migraine
    • Migraine Screening and Diagnosis
    • Migraine Treatment Guidelines
      • HCPC Guidelines
      • US Headache Consortium Guidelines
    • Migraine Treatment Options
    • Migraine Treatment Strategies
  • Help For Your Migraine Patients
  • Scientific Opinions
  • Learn about Zomig
  • eDetailing
  • Prescribing Information
  • Migraine Glossary and Useful Links
  • References
  • About AstraZeneca
  • Sitemap

You are here

  • Home
  • Treating Migraine
  • Migraine Treatment Guidelines

Despite the availability of migraine-specific medications such as the triptans, which are effective and well tolerated for the acute treatment of migraine, many migraineurs lapse from physician care before being prescribed an effective treatment. Indeed, the majority of patients who consult a physician about their headaches only do so on a single occasion. Patients default from care for a number of reasons, including a lack of consultation time, lack of professional knowledge about their condition, and a feeling that physicians do not take their condition seriously.

Two organisations have developed rational, evidence-based guidelines for migraine that are designed for use in daily clinical practice. These guidelines set standards for the management of patients with migraine from screening and diagnosis through to follow-up.

  • Headache Care for Practising Clinicians (HCPC) guidelines
  • US Headache Consortium guidelines

Back to top

Not signed in



  • Register
  • Forgotten password?

Page tools

  • Print
  • Bookmark this page

Clinical Product Summary

  • Zomig Nasal Spray
  • Zomig Rapimelt

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2008